BEIJING (Global Times): China's Sinopharm is expanding the production capacity to five billion doses per year with accelerating overseas cooperation after one of its Covid-19 vaccines was included in the Emergency Using List of the World Health Organisation (WHO), company executives said at a forum on Thursday (May 13) in Shanghai.
Sinopharm has produced more than 400 million doses of Covid-19 vaccines and more than 200 million doses have been supplied at home and abroad, Sinopharm executives said.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
